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Epidemiology, detection, and intervention/control of Cyclospora cayetanensis: A 
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Abstract 
Background: Cyclosporiasis is a food- and waterborne illness in humans caused by the consumption of 
contaminated food or water. As the causative agent, Cyclospora cayetanensis, has only been recently 
described, the published literature is limited and no scoping reviews on this topic have yet been 
conducted. 
Objectives: Our objective is to conduct a scoping review of the epidemiology, detection in matrix, and 
intervention/control of C. cayetanensis worldwide in humans, plant-based food, and in the environment 
with the aim of identifying gaps in the literature, potential areas where there may be sufficient literature to 
warrant a systematic review, and prioritizing future research directions. 
Eligibility criteria: All primary research, systematic reviews, scoping reviews and quantitative risk 
assessments in English, conducted anywhere in the world on the epidemiology, detection in matrix, and 
intervention/control of Cyclospora cayetanensis are eligible. Studies of the pathogenesis, diagnosis of 
illness in people, and treatment of cyclosporiasis are not eligible. 
Sources of evidence: The following databases will be searched: MEDLINE® (Web of ScienceTM), Agricola 
(ProQuest), CABI Global Health, and Food Science and Technology Abstracts (EBSCOhost) from 1979 to 
the present. 
Charting methods: We will extract information on general study characteristics, study purpose 
(epidemiology, detection, control) and within each of these categories, the study setting, study design, life 
cycle stage of Cyclospora investigated, and matrices tested. Based on the purpose of the study we will 
also extract the method of detection evaluated, risk factors for human illness, environmental and food 
contamination, incidence/prevalence in the environment and on food types, or the control approaches 
investigated. 
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Abstract 20 
Background: Cyclosporiasis is a food- and waterborne illness in humans caused by the 21 
consumption of contaminated food or water. As the causative agent, Cyclospora cayetanensis, 22 
has only been recently described, the published literature is limited and no scoping reviews on 23 
this topic have yet been conducted. 24 
Objectives: Our objective is to conduct a scoping review of the epidemiology, detection in 25 
matrix, and intervention/control of C. cayetanensis worldwide in humans, plant-based food, and 26 
in the environment with the aim of identifying gaps in the literature, potential areas where there 27 
may be sufficient literature to warrant a systematic review, and prioritizing future research 28 
directions. 29 
Eligibility criteria: All primary research, systematic reviews, scoping reviews and quantitative 30 
risk assessments in English, conducted anywhere in the world on the epidemiology, detection in 31 
matrix, and intervention/control of Cyclospora cayetanensis are eligible. Studies of the 32 
pathogenesis, diagnosis of illness in people, and treatment of cyclosporiasis are not eligible. 33 
Sources of evidence: The following databases will be searched: MEDLINE® (Web of 34 
ScienceTM), Agricola (ProQuest), CABI Global Health, and Food Science and Technology 35 
Abstracts (EBSCOhost) from 1979 to the present. 36 
Charting methods: We will extract information on general study characteristics, study purpose 37 
(epidemiology, detection, control) and within each of these categories, the study setting, study 38 
design, life cycle stage of Cyclospora investigated, and matrices tested. Based on the purpose of 39 
the study we will also extract the method of detection evaluated, risk factors for human illness, 40 
environmental and food contamination, incidence/prevalence in the environment and on food 41 
types, or the control approaches investigated. 42 
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1. Introduction 43 
1.1. Rationale 44 
Cyclospora cayetanensis is a single-celled parasite that causes an illness called cyclosporiasis in 45 
humans when a person consumes water or food contaminated with the organism (CDC, 2019). C. 46 
cayetanensis is shed in the feces by infected people. After 1 to 2 weeks in the environment, the 47 
organism reaches the life cycle stage (sporulated oocyst) that is infectious to other people (CDC, 48 
2019). Although the disease most commonly occurs in tropical and subtropical regions, people in 49 
all parts of the world may become infected via ingestion of contaminated fresh produce imported 50 
from those regions, with a recent outbreak occurring in the USA in 2019 linked to basil from 51 
Mexico (CDC, 2019).  52 
 53 
Scoping reviews are a type of literature review used for knowledge synthesis (Munn et al., 2018; 54 
Tricco et al., 2018). Scoping reviews use systematic and transparent methods to summarize 55 
research on broad topics, map the available evidence, and identify gaps in the current knowledge 56 
(Tricco et al., 2018). A scoping review may act as a prelude to a systematic review and/or it may 57 
help direct the focus of future primary research by highlighting areas where no research has been 58 
conducted (Munn et al., 2018).  59 
 60 
C. cayetanensis was first reported in humans in 1979 (Ashford, 1979) but it was not fully 61 
identified until the early 1990s (Ortega and Sanchez, 2010). The literature base on this organism 62 
consequently appears to be relatively limited; preliminary searches for existing scoping reviews 63 
and systematic reviews of Cyclospora were conducted on December 12th, 2019 in MEDLINE® 64 
(Web of ScienceTM) (dates searched: 1950-Present), Agricola (ProQuest) (dates searched: 1970-65 
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Present), and CABI Global Health (dates searched: 1973-present) using the search terms 66 
["Cyclospora" AND "systematic review"] and ["Cyclospora" AND "scoping review"]. The same 67 
search was conducted in Food Science and Technology Abstracts (EBSCOhost) on January 3rd 68 
2020. No scoping or systematic reviews of Cyclospora were found.  69 
 70 
1.2. Objectives 71 
Our objective is to conduct a scoping review of the epidemiology, intervention/control, and 72 
detection in matrix of Cyclospora cayetanensis worldwide in humans, plant-based food, and in 73 
the growing environment, i.e. water and soil, with the aim of identifying research gaps in the 74 
literature and prioritizing future research directions, and identifying topics with sufficient 75 
evidence base for systematic reviews. 76 
 77 
2. Methods 78 
2.1. Protocol and registration 79 
This protocol was drafted using the Preferred Reporting Items for Systematic Reviews and Meta-80 
Analyses Extension for Scoping Reviews (PRISMA-ScR) (Tricco et al., 2018). This protocol 81 
will be registered on the University of Guelph Atrium and can be accessed at SYREAF 82 
[www.syreaf.org].  83 
 84 
2.2. Eligibility criteria 85 
Studies included in the review must be:  86 
1) published in English (though studies in English from any part of the world are eligible);  87 
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2) primary research, systematic reviews, scoping reviews, or quantitative risk assessments 88 
(QRA) only. Narrative or non-systematic reviews will not be eligible for inclusion, as the 89 
absence of reported methods precludes the assessment of rigor and comprehensiveness; 90 
 3) studies of Cyclospora cayetanensis, as this is the only species of Cyclospora that causes 91 
cyclosporiasis in humans (CDC, 2019). Studies that report only Cyclospora species but do not 92 
specify that the organism is C. cayetanensis will therefore not be eligible.; 4) studies of any life 93 
stage (oocysts, sporocysts, or sporozoites) in any exposure source (soil, water and plants-based 94 
food).  95 
In humans, direct person-to-person transmission of cyclosporiasis does not occur (CDC, 2019) 96 
therefore this is not of interest to the review. According to the CDC, animals have not been 97 
documented as an intermediate or primary host of C. cayetanensis and therefore animal studies 98 
are not of interest. Studies of the diagnosis of human illness, pathogenesis, and treatment of 99 
cyclosporiasis are not eligible for this review. 100 
 101 
2.3. Information sources 102 
To identify relevant studies, the following databases will be searched from 1979 to the present: 103 
MEDLINE® (Web of ScienceTM), Agricola (ProQuest), CABI Global Health, and Food Science 104 
and Technology Abstracts (EBSCOhost). As the focus of this scoping review is broad and the 105 
topic is relatively new, we consider it appropriate to conduct a simple search  (with no 106 
restrictions on study design or research focus) that will not require specialized information 107 
retrieval knowledge; therefore the review team  designed the search without input from a library 108 
scientist.  Results of the database searches will be uploaded into Endnote® X8 Desktop for de-109 
duplication. The resulting de-duplicated results will be imported into DistillerSR® (Evidence 110 
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Partners, Ottawa, ON, Canada) review management software for further de-duplication. We will 111 
also scan the reference lists of ten (subject to availability) of the most recently published 112 
narrative reviews for additional relevant studies. We will not be contacting authors to identify 113 
additional studies.  114 
 115 
2.4. Search 116 
The search strategy for MEDLINE® is in Table 1, Agricola (ProQuest) is in Table 2, CABI 117 
Global Health is in Table 3, and for Food Science and Technology Abstracts (EBSCOhost) is in 118 
Table 4, and will be conducted by members of the review team (AOC and ST). Given the 119 
simplicity of the search string we did not submit the search strategy for peer review. There will 120 
be no document-type or language restrictions included in the search, but the search will be 121 
limited to studies published from 1979 to the date of the search, since C. cayetanensis was first 122 
reported in humans in this year (Ashford, 1979). We did evaluate the addition of a wildcard (*) 123 
term in the search ( cyclospor*) however this was not included in the final search because it 124 
added tremendously to the search results but the majority of new citations were irrelevant studies 125 
on the antibiotic Cyclosporine A, a cyclic nonribosomal peptide, cyclosporin (a polypeptide). 126 
Adding the terms Title (TI), MeSH Heading or MESH Major Topic did not add identify any 127 
unique hits to the search 128 
 129 
Table 1: Proposed search strategy1 in MEDLINE® (Web of ScienceTM) for a scoping review of the epidemiology, detection, and 130 















4 #3 OR #2 OR #1 
1 There will be no document type or language restrictions. 133 
 134 
Table 2:Proposed search strategy in Agricola (ProQuest) for a scoping review of the epidemiology, detection, and 135 
intervention/control of Cyclospora cayetanensis.  136 
Search no. Search string 
1 cyclospora OR cyclosporiasis OR cayetanensis 
Search will be from January 1st, 1979 to present. 137 
There will be no restrictions on source type, document type, or language. 138 
 139 
Table 3: Proposed search strategy in CABI Global Health for a scoping review of the epidemiology, detection, and 140 
intervention/control of Cyclospora cayetanensis. 141 
Search no. Search string 
1 (cyclospora) OR (cyclosporiasis) OR (cayetanensis) AND yr:[1979 TO 2020] 
Search will be from 1979 to present with no document type restrictions. Search of "all fields." 142 
 143 
Table 4: Proposed search strategy in food science and technology abstracts  144 
Search no. Search string 
1 (cyclospora) OR (cyclosporiasis) OR (cayetanensis) AND yr:[1979 TO 2020] 
 145 
 146 
2.5. Selection of sources of evidence 147 
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In DistillerSR®, two reviewers working independently will assess the retrieved records for 148 
eligibility, first based on the title/abstract, then, if they are deemed likely to be relevant, on the 149 
full text.  For eligibility assessment based on the title/abstract, two reviewers will be required to 150 
exclude any record. For eligibility assessment based on the full text, two reviewers will be 151 
required to include or exclude any record. Conflicts will be resolved via discussion, and if 152 
consensus cannot be reached, by consulting a third reviewer.  153 
 154 
The title/abstract screening form was pre-tested by all reviewers on 100 records and revised as 155 
needed for clarity and consistency, before screening begins. This form comprises the following 156 
question: 157 
 158 
 Q1. Based on the title/abstract, is the study a systematic review, a scoping review, a  159 
        QRA, a computer model (in silico) study, a burden of illness study, a molecular 160 
characterization study or primary  161 
         research on detection in matrix, epidemiology of the exposure source, epidemiology  162 
        of human exposure, and/or intervention/control of the exposure source in Cyclospora  163 
        cayetanensis? 164 
  a. Yes (proceed to full-text screening) 165 
  b. No (exclude) 166 
  c. Unclear (proceed to full-text screening)  167 
  d. No, but it may be a relevant narrative review (exclude) 168 
 169 
Cyclospora Scoping Review Protocol/Page 8 
 
The full-text screening form was pre-tested by all reviewers on five records and revised for 170 
clarity and consistency prior to the beginning of screening. This form comprises the following 171 
questions: 172 
 173 
 Q1. Is the full text available in English? 174 
  a. Yes (proceed to Q2) 175 
  b. No, the full text is not in English (exclude) Specify language _________ 176 
  c. No, the full text is not available (exclude) 177 
 Q2. Does the full text describe a study on Cyclospora cayetanensis? 178 
  a. Yes (proceed to Q3) 179 
  b. No (The study is of a different species of Cyclospora) (exclude) 180 
  c. No (The study is not on Cyclospora at all) (exclude) 181 
 Q3. Does the full text describe primary research, a systematic review, a scoping review, a  182 
        computer model study, a burden of illness study or a QRA of Cyclospora  183 
        cayetanensis? 184 
  a. Yes (proceed to Q4) 185 
  b. No (exclude) 186 
  c. No but this is a potentially relevant narrative review (exclude) 187 
 Q4. If this is primary research, does the full text describe a study on the detection in  188 
          matrix, epidemiology of the exposure source, epidemiology of human exposure,  189 
  and/or intervention/control of the exposure source in Cyclospora cayetanensis? 190 
  a. Yes (proceed to data extraction) 191 
  b. No (This is a study of cyclosporiasis treatment in humans) (exclude) 192 
Cyclospora Scoping Review Protocol/Page 9 
 
  c. No (This is a study of the pathogenesis of cyclosporiasis) (exclude) 193 
  d. No (This is an animal study) (specify species tested) (exclude) 194 
  e. No (This is a study of diagnosis of illness in humans) (exclude) 195 
  f. No (The study is not relevant for other reasons (exclude) 196 
  g. This is a computer model study, a burden of illness study or a QRA (include) 197 
 198 
The total number of articles originating from each database searched, the number remaining after 199 
de-duplication, and the number of studies assessed at title/abstract and full-text screening (with 200 
reasons for exclusion for the latter) will be reported in a PRISMA Flow Diagram. 201 
 202 
2.6. Data charting process 203 
Data charting will take place in DistillerSR®. Data will be charted from all eligible studies by 204 
two reviewers working independently, using a data-charting form designed for this review that 205 
was pre-tested by all reviewers on five studies, with subsequent revision for clarity and ease of 206 
use before charting begins. Conflicts will be resolved through discussion or, when this is not 207 
possible, by consulting a third reviewer. Authors of eligible studies will not be contacted for 208 
clarification/additional information. 209 
 210 
2.7. Data items 211 
Reviewers will extract the following categories of data: 212 
  213 
 Study types: 214 
  Primary research 215 
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  Quantitative risk assessment 216 
  In silico model 217 
  Burden of illness study 218 
  Systematic review* 219 
  Scoping review* 220 
* As our preliminary search did not detect any systematic or scoping reviews, we expect that we 221 
may not find either of these types of studies in the final database search. 222 
 223 
The following data will be collected for primary research studies only: 224 
 General study characteristics: 225 
  Year(s) and month(s) of study conduct if reported  226 
  Location (country) in which the study was conducted 227 
 228 
 What was the purpose of the study? 229 
1. Epidemiology (incl. transmission to humans, to the environment, to food) 230 
1.1. Human infection 231 
1.1.1. What was the study population? 232 
 1.1.1.1. Outbreak 233 
 1.1.1.2. Non-outbreak 234 
  1.1.1.2.1 If non-outbreak, specify the population 235 
• Immuno-compromised, organ transplant, HIV, etc. 236 
• Hospital cases (immune state not specified) – retrospective 237 
evaluation of cases   238 
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• Non- hospitalized Non-immunocompromised populations 239 
(health workers, agricultural workers, etc.)  240 
1.1.1. Prevalence study 241 
1.1.1.1. Prevalence of the organism or some molecular subtype of the organism 242 
1.1.1.2. Demographics of the exposed population 243 
1.1.2. Risk Factor study 244 
1.1.2.1. What risk factors were investigated (could include genotype)?  245 
1.2. Exposure source  246 
 1.2.1. Specify exposure source(s) evaluated (berries/food, water, soil) 247 
  1.2.1.1. If produce, specify the type of produce investigated. 248 
   1.2.1.1.1. If produce, specify: fresh vs frozen, domestic vs  249 
    imported, processed vs unprocessed, hand-picked vs  250 
    mechanically harvested 251 
  1.2.1.2. If water, specify recreational, irrigation, natural, runoff, sewage 252 
  1.2.1.3. If soil, specify agricultural, compost, other 253 
    1.2.2.  Specify if this was an Outbreak or a Non-outbreak study. 254 
    1.2.3.  What was the purpose of the study? (Prevalence or Risk Factor study) 255 
  1.2.3.1. If this was a Prevalence \study, did the authors report the 256 
    prevalence of the organism and/or molecular subtypes of the  257 
    organism? 258 
  1.2.3.2. If this was a Risk Factor study, what factors were investigated? 259 
 260 
1.3. Molecular Characterization of Cyclospora 261 
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2. Detection Method Development and Validation Study 262 
2.1. Specify matrix (water, soil, human feces, etc.) 263 
2.2. What stage of the life cycle of Cyclospora are they detecting? 264 
2.3. Natural or challenge 265 
2.4. What detection methods were used (PCR, Light microscopy, UV microscopy, Other)? 266 
3. Control (intervention) study 267 
3.1. What was the matrix (exposure source or Petri dish) they applied the intervention to?  268 
3.1.1. If it's a matrix, at what stage was the intervention applied (pre-harvest, post-269 
harvest, etc.)? 270 
3.1.2. What life cycle stage of Cyclospora was the control used against? 271 
3.1.3. Natural infection vs challenge 272 
3.1.4. What was the control (intervention) used? (type, method of application) 273 
3.1.5. Describe the comparison group. 274 
  275 
2.8. Critical appraisal of individual sources of evidence 276 
As this is a scoping review, we will not conduct a critical appraisal of the literature. 277 
 278 
2.9. Synthesis of results 279 
The results will be summarized with descriptive statistics reporting the frequency of topics 280 
investigated using a combination of tables and narrative text. Results of this review will be used 281 
to identify knowledge gaps and help prioritize research directions, including areas for potential 282 
systematic review for the control of Cyclospora cayetanensis in produce. 283 
 284 
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